Healthcare -
Biotechnology - NASDAQ - CH
$ 40.53
0.571 %
$ 3.46 B
Market Cap
-14.53
P/E
CRSP - LONG-TERM DEBT
Long-term Debt CRSP - CRISPR Therapeutics AG
223 M
LAST VALUE
2.35%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR